PP
VanEck Pharmaceutical ETF (PPH)
NASDAQ
109.18
-0.31 (-0.28%)
Real-time Data
01:30 PM
Day's Range
107.05109.28
52 wk Range
90.60118.00
Overview - PPH - VanEck Pharmaceutical ETF
Key Statistics
Valuation
P/E (Trailing)
‪23.52‬
Price stats
50-Day Avg
‪112.03‬
200-Day Avg
‪106.99‬
Dividends
Frequency
Quarterly
Market Cap - PPH - VanEck Pharmaceutical ETF
Peers - PPH - VanEck Pharmaceutical ETF
Peer Comparison
Compared with other ETFs.
- PPPPHNASDAQVanEck Pharmaceutical ETF1.14BMarket Cap+13.27%52-week change23.53P/E (Trailing)—Profit Margin
- DVDVYNASDAQiShares Select Dividend ETF26.67BMarket Cap+6.64%52-week change14.55P/E (Trailing)—Profit Margin
- DUDUKHNASDAQOcean Park High Income ETF16.90BMarket Cap-6.25%52-week change15.29P/E (Trailing)—Profit Margin
- CSCSBNASDAQVictoryShares US Small Cap High Div Volatility Wtd ETF13.02BMarket Cap+4.86%52-week change13.24P/E (Trailing)—Profit Margin
- CSCSBIXNASDAQCromwell Balanced Fund Institutional Class6.82BMarket Cap-2.48%52-week change24.96P/E (Trailing)—Profit Margin
- CALYNASDAQBlackRock Short-Term California Muni Bond ETF2.54BMarket Cap+32.91%52-week change33.35P/E (Trailing)‪-12.36%‬Profit Margin
- DVGRNASDAQDAC 3D Dividend Growth ETF1.33BMarket Cap+3.10%52-week change22.34P/E (Trailing)‪19.40%‬Profit Margin
Profile Summary - PPH - VanEck Pharmaceutical ETF
About
VanEck Pharmaceutical ETF is an exchange-traded fund that provides focused exposure to the pharmaceutical industry through a portfolio of U.S.-listed companies involved in drug discovery, development, production, marketing, and sales. The fund is designed to track the MVIS US Listed Pharmaceutical 25 Index, giving…
Employees0
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
